Location History:
- Tokushima, JP (2010)
- Osaka, JP (2012 - 2019)
Company Filing History:
3 out of 846 
2 out of 26 
1 out of 1 Years Active: 2010-2019
Title: Suguru Akamatsu: Innovator in Metabolic Measurement
Introduction
Suguru Akamatsu is a prominent inventor based in Osaka, Japan, known for his significant contributions to the field of metabolic measurement. With a total of five patents to his name, Akamatsu has developed innovative methods and compositions that enhance the understanding of glucose metabolism and its implications for diabetes.
Latest Patents
Akamatsu's latest patents include a groundbreaking method for measuring carbohydrate metabolism ability. This method allows for rapid and accurate evaluation of a subject's glucose metabolism using a labeled C-breath test. The composition utilized in this method contains glucose labeled with isotopes of carbon, which is converted in the subject to labeled carbon dioxide exhaled in expired air. This innovative approach not only determines the stage of diabetes in patients but also monitors their condition over time.
Another notable patent is a monoclonal antibody designed for analyzing high-molecular weight adiponectin. This antibody specifically reacts with high-molecular weight adiponectin without cross-reactivity with middle-molecular weight adiponectin. The development of this antibody provides a high-accuracy and versatile reagent for analyzing adiponectin levels, which is crucial for understanding metabolic health.
Career Highlights
Throughout his career, Suguru Akamatsu has worked with esteemed organizations such as Otsuka Pharmaceutical Company and LSI Medience Corporation. His experience in these companies has significantly contributed to his expertise in metabolic research and innovation.
Collaborations
Akamatsu has collaborated with notable colleagues, including Ayako Nishimura and Kiyonori Katsuragi, who have played a role in advancing his research and patent developments.
Conclusion
Suguru Akamatsu's innovative work in metabolic measurement and his contributions to diabetes research highlight his importance in the field. His patents reflect a commitment to improving health outcomes through scientific advancements.